JC

Jeffrey Cauble

Director Director DIN 08647943
DIN 08647943 First appointment Jan 2020 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jan 2020
Shareholding value Locked Premium profile

About Jeffrey Cauble

Data last updated:

Jeffrey Cauble has 6 years in corporate governance. Formerly with 1 company, such as Totipotentrx Cell Therapy Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08647943
Primary Designation Director
First Appointment 14 Jan 2020
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director14 Jan 20202011Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Totipotentrx Cell Therapy Private Limited
Premium access

Shareholding and investment profile for Jeffrey Cauble

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jeffrey Cauble

Jeffrey Cauble has 6 years in corporate governance. Formerly with 1 company, such as Totipotentrx Cell Therapy Private Limited. Engaged in General Business. Contributes to corporate operations.

Jeffrey Cauble is associated with 0 companies as a director.

Jeffrey Cauble has expertise in General Business.

Jeffrey Cauble has 6 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available